
Instalab
At-home blood testing kits and biomarker analysis for proactive health monitoring and personalized insights.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
* | N/A | $500k | Seed |
Total Funding | 000k |
Related Content
Instalab, a health-focused company, provides at-home blood testing services. The company offers a subscription-based model where customers receive blood testing kits every three months. These kits are used to collect samples at home, which are then sent to a lab for analysis. The results provide insights into various biomarkers, helping customers to monitor and proactively manage their health.
The service is designed for individuals who want to take a proactive approach to their health and wellness. By tracking biomarkers over time, customers can identify trends and make informed decisions about their lifestyle and diet. The company operates in the direct-to-consumer healthcare market, leveraging the growing interest in personalized health and at-home testing.
Keywords: at-home testing, blood testing, preventative healthcare, biomarker tracking, subscription service, personalized health, direct-to-consumer, health and wellness, medical diagnostics, proactive health